201 related articles for article (PubMed ID: 34071043)
1. TFEB Overexpression, Not mTOR Inhibition, Ameliorates RagC
Kim M; Lu L; Dvornikov AV; Ma X; Ding Y; Zhu P; Olson TM; Lin X; Xu X
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071043
[TBL] [Abstract][Full Text] [Related]
2. De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy.
Long PA; Zimmermann MT; Kim M; Evans JM; Xu X; Olson TM
Hum Genet; 2016 Aug; 135(8):909-917. PubMed ID: 27234373
[TBL] [Abstract][Full Text] [Related]
3. TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism.
Alesi N; Akl EW; Khabibullin D; Liu HJ; Nidhiry AS; Garner ER; Filippakis H; Lam HC; Shi W; Viswanathan SR; Morroni M; Ferguson SM; Henske EP
Nat Commun; 2021 Jul; 12(1):4245. PubMed ID: 34253722
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X
J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219
[TBL] [Abstract][Full Text] [Related]
5. Haploinsufficiency of mechanistic target of rapamycin ameliorates
Ding Y; Dvornikov AV; Ma X; Zhang H; Wang Y; Lowerison M; Packard RR; Wang L; Chen J; Zhang Y; Hsiai T; Lin X; Xu X
Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31492659
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells.
Marchand B; Arsenault D; Raymond-Fleury A; Boisvert FM; Boucher MJ
J Biol Chem; 2015 Feb; 290(9):5592-605. PubMed ID: 25561726
[TBL] [Abstract][Full Text] [Related]
7. Structure of the lysosomal mTORC1-TFEB-Rag-Ragulator megacomplex.
Cui Z; Napolitano G; de Araujo MEG; Esposito A; Monfregola J; Huber LA; Ballabio A; Hurley JH
Nature; 2023 Feb; 614(7948):572-579. PubMed ID: 36697823
[TBL] [Abstract][Full Text] [Related]
8. Curcumin targets the TFEB-lysosome pathway for induction of autophagy.
Zhang J; Wang J; Xu J; Lu Y; Jiang J; Wang L; Shen HM; Xia D
Oncotarget; 2016 Nov; 7(46):75659-75671. PubMed ID: 27689333
[TBL] [Abstract][Full Text] [Related]
9. De novo missense variants in RRAGC lead to a fatal mTORopathy of early childhood.
Reijnders MRF; Seibt A; Brugger M; Lamers IJC; Ott T; Klaas O; Horváth J; Rose AMS; Craghill IM; Brunet T; Graf E; Mayerhanser K; Hellebrekers D; Pauck D; Neuen-Jacob E; Rodenburg RJT; Wieczorek D; Klee D; Mayatepek E; Driessen G; Bindermann R; Averdunk L; Lohmeier K; Sinnema M; Stegmann APA; Roepman R; Poulter JA; Distelmaier F
Genet Med; 2023 Jul; 25(7):100838. PubMed ID: 37057673
[TBL] [Abstract][Full Text] [Related]
10. TFEB-driven endocytosis coordinates MTORC1 signaling and autophagy.
Nnah IC; Wang B; Saqcena C; Weber GF; Bonder EM; Bagley D; De Cegli R; Napolitano G; Medina DL; Ballabio A; Dobrowolski R
Autophagy; 2019 Jan; 15(1):151-164. PubMed ID: 30145926
[TBL] [Abstract][Full Text] [Related]
11. Raptor mediates the selective inhibitory effect of cardamonin on RRAGC-mutant B cell lymphoma.
Liu Y; Zhu Y; Chen H; Zhou J; Niu P; Shi D
BMC Complement Med Ther; 2023 Sep; 23(1):336. PubMed ID: 37749558
[TBL] [Abstract][Full Text] [Related]
12. AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR.
Collodet C; Foretz M; Deak M; Bultot L; Metairon S; Viollet B; Lefebvre G; Raymond F; Parisi A; Civiletto G; Gut P; Descombes P; Sakamoto K
FASEB J; 2019 Nov; 33(11):12374-12391. PubMed ID: 31404503
[TBL] [Abstract][Full Text] [Related]
13. Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes.
Martina JA; Puertollano R
J Cell Biol; 2013 Feb; 200(4):475-91. PubMed ID: 23401004
[TBL] [Abstract][Full Text] [Related]
14. mTOR-Activating Mutations in
Schlingmann KP; Jouret F; Shen K; Nigam A; Arjona FJ; Dafinger C; Houillier P; Jones DP; Kleinerüschkamp F; Oh J; Godefroid N; Eltan M; Güran T; Burtey S; Parotte MC; König J; Braun A; Bos C; Ibars Serra M; Rehmann H; Zwartkruis FJT; Renkema KY; Klingel K; Schulze-Bahr E; Schermer B; Bergmann C; Altmüller J; Thiele H; Beck BB; Dahan K; Sabatini D; Liebau MC; Vargas-Poussou R; Knoers NVAM; Konrad M; de Baaij JHF
J Am Soc Nephrol; 2021 Nov; 32(11):2885-2899. PubMed ID: 34607910
[TBL] [Abstract][Full Text] [Related]
15. The Lysosomal Transcription Factor TFEB Represses Myelination Downstream of the Rag-Ragulator Complex.
Meireles AM; Shen K; Zoupi L; Iyer H; Bouchard EL; Williams A; Talbot WS
Dev Cell; 2018 Nov; 47(3):319-330.e5. PubMed ID: 30399334
[TBL] [Abstract][Full Text] [Related]
16. TFEB activation protects against cardiac proteotoxicity via increasing autophagic flux.
Pan B; Zhang H; Cui T; Wang X
J Mol Cell Cardiol; 2017 Dec; 113():51-62. PubMed ID: 28993153
[TBL] [Abstract][Full Text] [Related]
17. Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis.
Wang S; Ni HM; Chao X; Wang H; Bridges B; Kumer S; Schmitt T; Mareninova O; Gukovskaya A; De Lisle RC; Ballabio A; Pacher P; Ding WX
Autophagy; 2019 Nov; 15(11):1954-1969. PubMed ID: 30894069
[TBL] [Abstract][Full Text] [Related]
18. Transcription Factor EB Activation Rescues Advanced αB-Crystallin Mutation-Induced Cardiomyopathy by Normalizing Desmin Localization.
Ma X; Mani K; Liu H; Kovacs A; Murphy JT; Foroughi L; French BA; Weinheimer CJ; Kraja A; Benjamin IJ; Hill JA; Javaheri A; Diwan A
J Am Heart Assoc; 2019 Feb; 8(4):e010866. PubMed ID: 30773991
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of LAPTM4B Contributes to the Impairment of the Autophagic Flux via Unopposed Activation of mTORC1 Signaling During Myocardial Ischemia/Reperfusion Injury.
Gu S; Tan J; Li Q; Liu S; Ma J; Zheng Y; Liu J; Bi W; Sha P; Li X; Wei M; Cao N; Yang HT
Circ Res; 2020 Sep; 127(7):e148-e165. PubMed ID: 32693673
[TBL] [Abstract][Full Text] [Related]
20. Time course decomposition of cell heterogeneity in TFEB signaling states reveals homeostatic mechanisms restricting the magnitude and duration of TFEB responses to mTOR activity modulation.
Marin Zapata PA; Beese CJ; Jünger A; Dalmasso G; Brady NR; Hamacher-Brady A
BMC Cancer; 2016 Jun; 16():355. PubMed ID: 27268034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
